ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

In Brief: Hatch Restores NCI Budget Bypass Authority In His Bill Renewing National Cancer Act

April 23, 1982

NCI contract Award

August 1, 1997